Insider Cluster (10 insiders) ·Filed Jun 26, 2026

KYMR

Kymera Therapeutics, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago
Insider cluster: 3 insiders, $90.6M total
Actionable Insight ▼ Bearish

The large BVF Partners sale is the dominant signal; monitor for any forthcoming pipeline updates or earnings pre-announcements that may have prompted the reduction. Given the size, this could precede a negative catalyst or reflect a strategic shift by a key holder. Watch for additional insider filings in the coming weeks.

DirectionBearish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
KYMR ▲ +11.65% at T+60d
SHORT call ✗ call lost -11.65% · α vs SPY -7.27% · entry $109.32 → $122.06
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
+4.89%
call -4.89% · α -4.12%
$114.67
settled 3mo ago
T+5d
+4.98%
call -4.98% · α -3.59%
$114.76
settled 3mo ago
T+20d
+1.14%
call -1.14% · α -1.42%
$110.57
settled 2mo ago
T+60d
+11.65%
call -11.65% · α -7.27%
$122.06
settled 10d ago

Price Chart

Loading chart...

Executive Summary

A significant insider selling cluster at Kymera Therapeutics, led by director BVF Partners' $89.2M open-market sale, totaling $90.6M in sales over a week. This represents ~0.94% of market cap, a material reduction by a major shareholder. The selling is concentrated among directors, with only a small C-suite sale, suggesting potential portfolio rebalancing or a cautious view on near-term catalysts.

Key Financial Metrics

Direction
selling
Total Value
$90.6M
Insiders
10

Key Facts

  • BVF Partners (director) sold 837,914 shares for $89.2M on 2026-06-26.
  • Director Bruce Booth sold ~185,330 shares totaling ~$19.3M across multiple trades.
  • Chief Business Officer Noah Goodman sold 2,500 shares for $272,500 (small relative to total).
  • Total open-market sales of $90.6M represent ~0.94% of Kymera's $9.6B market cap.
  • 10 unique insiders filed Form 4s in the cluster window, but only 3 engaged in open-market selling.

Financial Impact

Insider selling of $90.6M, or 0.94% of market cap, concentrated in director-level sales.

insider ownershipmarket sentiment

Risk Factors

  • Further insider selling could pressure the stock.
  • Potential negative clinical or regulatory news may be anticipated by insiders.
  • High institutional ownership (93% analyst bullish) may buffer but does not guarantee price stability.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KYMR-1782514125315
30 reports for KYMR
Performance horizon
73% Hit rate 8 of 11 directional calls best @ T+60▲ +60.99%Jun 8, 2026
Filters
Rows
Reports for KYMR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$105.48 $118.63▲ +12.47%▲ +13.07%$107.39 (+1.81%)
Jul 8, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$114.16 $105.48▲ +7.60%▲ +10.88%$107.39 (+5.93%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jun 30, 2026
13w ago
144
BEARISH ★ 4/10
$114.20 $105.25▲ +7.84%▲ +5.65%$107.39 (+5.96%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 4/10
$114.67 $110.05▼ −4.03%▼ −3.00%$107.39 (−6.35%)
Jun 26, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$116.46 $110.38▼ −5.22%▼ −5.75%$107.39 (−7.79%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 26, 2026